Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeorgia Capital Regulatory News (CGEO)

Share Price Information for Georgia Capital (CGEO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,332.00
Bid: 1,330.00
Ask: 1,336.00
Change: 18.00 (1.37%)
Spread: 6.00 (0.451%)
Open: 1,314.00
High: 1,340.00
Low: 1,314.00
Prev. Close: 1,314.00
CGEO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Georgia Capital plc

18 May 2020 12:12

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: COELI FRONTIER MARKETS AB
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

OFFEROR: Georgia Capital plc, GB00BF4HYV08

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

2020-05-14
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

OFFEREE: Georgia Healthcare Group plc, GB00BYSS4K11

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 1p ordinary

Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 621 865 1,548
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

621 865 1,548

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security Purchase/sale Number of securities Price per unit
1p ordinary Sale 24287 4,1828

(b) Cash-settled derivative transactions

Class of relevant security Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities Price per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 2020-05-18
Contact name: Joakim Lundmark
Telephone number*: +46 (0)709379752

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200518005361/en/

Copyright Business Wire 2020

Date   Source Headline
6th Oct 20217:00 amRNSTransaction in Own Shares
1st Oct 20213:05 pmRNSTotal Voting Rights
1st Oct 20212:54 pmRNSHolding(s) in Company
30th Sep 20215:50 pmRNSCancellation of Treasury Shares
27th Sep 20215:35 pmRNSTransaction in Own Shares
23rd Sep 20215:41 pmRNSTransaction in Own Shares
20th Sep 20216:27 pmRNSTransaction in Own Shares
14th Sep 20215:38 pmRNSTransaction in Own Shares
10th Sep 20219:59 amRNSHolding(s) in Company
8th Sep 20215:30 pmRNSTransaction in Own Shares
2nd Sep 20212:14 pmRNSDirector/PDMR Shareholding
1st Sep 20215:18 pmRNSTotal Voting Rights
31st Aug 20216:18 pmRNSTransaction in Own Shares
26th Aug 20217:00 amRNSDirector/PDMR Shareholding
25th Aug 20216:25 pmRNSTransaction in Own Shares
25th Aug 20217:00 amRNSExpansion of the education business
23rd Aug 20215:15 pmRNSDirector/PDMR Shareholding
19th Aug 20215:55 pmRNSTransaction in Own Shares
19th Aug 20217:00 amRNSTransaction in Own Shares
12th Aug 20215:48 pmRNSDirector Declaration
12th Aug 202111:05 amRNSHolding(s) in Company
11th Aug 20217:00 amRNSTransaction in Own Shares
10th Aug 20217:00 amRNSHalf-year Report
26th Jul 202111:00 amRNSGeorgia Capital PLC Notice of 2Q21 & 1H21 Results
13th Jul 20211:38 pmRNSDirector/PDMR Shareholding - Replacement
12th Jul 20212:16 pmRNSHolding(s) in Company
9th Jul 20214:05 pmRNSHolding(s) in Company
8th Jul 20212:40 pmRNSUpdate on BOG’s minimum capital requirements
6th Jul 20216:04 pmRNSDirector/PDMR Shareholding
1st Jul 20214:13 pmRNSDirector/PDMR Shareholding - Replacement
30th Jun 20215:17 pmRNSDirector/PDMR Shareholding
30th Jun 20217:00 amRNSRule 19.6(c) announcement - Georgia Capital PLC
29th Jun 20211:30 pmRNSGHG digital application winning Gold Award
21st Jun 20217:00 amRNSTrading Statement
3rd Jun 202111:41 amRNSDirector/PDMR Shareholding
1st Jun 202111:41 amRNSDirector/PDMR Shareholding
28th May 20212:19 pmRNSDirector/PDMR Shareholding
26th May 20217:00 amRNSDirector/PDMR Shareholding
25th May 20215:22 pmRNSResult of AGM
19th May 20217:00 amRNSUpdate on AGM 2021
18th May 20217:00 amRNS1st Quarter Results
11th May 202111:29 amRNSNotice of Results
13th Apr 20217:00 amRNSNotice of AGM
30th Mar 20212:34 pmRNSDirector/PDMR Shareholding
26th Mar 202111:30 amRNSDirector/PDMR Shareholding
26th Mar 202110:17 amRNSDirector/PDMR Shareholding
26th Mar 20217:00 amRNSAnnual Financial Report
24th Mar 20216:04 pmRNSDirector/PDMR Shareholding
22nd Mar 20216:29 pmRNSHolding(s) in Company
22nd Mar 20215:50 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.